FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to a method for predicting the risk of developing insulin resistance. The method for predicting the risk of developing insulin resistance includes examining the levels of apolipoproteins B (apoB) and A1 (apoA1) in the patient's venous blood, calculating the ratio of apolipoprotein B / apolipoprotein A1, where with an increase in the apoB / apoA1 ratio within 0.57-0.70, the average risk is diagnosed development of insulin resistance, in the range of 0.71-0.85 - a high risk, and above 0.86 a - very high risk of developing insulin resistance is diagnosed.
EFFECT: above method ensures early and accurate prediction of the risk of developing insulin resistance.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS IN PATIENTS WITH METABOLIC SYNDROME | 2003 |
|
RU2264170C2 |
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC COMPLICATIONS OF OBESITY IN CHILDREN | 2024 |
|
RU2821562C1 |
| METHOD OF DIAGNOSING VISCERAL ADIPOPEXIS BY METHOD OF ECHOCARDIOGRAPHY IN CHILDREN AND TEENAGERS | 2009 |
|
RU2427319C2 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN SCHIZOPHRENIC PATIENTS RECEIVING NEUROLEPTIC THERAPY | 2019 |
|
RU2717367C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING VASCULAR LESIONS AT EARLY STAGES OF CARBOHYDRATE METABOLISM DISORDERS | 2019 |
|
RU2735706C1 |
| METHOD OF DIAGNOSING METABOLIC SYNDROME | 2010 |
|
RU2444298C1 |
